Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017926HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10017460HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10033096HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10035096HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10018412HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10019448HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS10045150HBVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS30011672HIVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS30002004HIVENSG00000175899.15protein_codingA2MNoNo2P01023
TVIS30080257HIVENSG00000175899.15protein_codingA2MNoNo2P01023
TCGA Plot Options
Drug Information
GeneA2M
DrugBank IDDB00626
Drug NameBacitracin
Target IDBE0000910
UniProt IDP01023
Regulation Typeinhibitor
PubMed IDs42903; 6162847; 6165617; 6184373; 6187372
CitationsMaxfield FR, Davies PJ, Klempner L, Willingham MC, Pastan I: Epidermal growth factor stimulation of DNA synthesis is potentiated by compounds that inhibit its clustering in coated pits. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5731-5.@@Dickson RB, Willingham MC, Pastan I: Binding and internalization of 125I-alpha 2-macroglobulin by cultured fibroblasts. J Biol Chem. 1981 Apr 10;256(7):3454-9.@@Dickson RB, Willingham MC, Gallo M, Pastan I: Inhibition by bacitracin of high affinity binding of 125I-alpha 2M to plasma membranes. FEBS Lett. 1981 Apr 20;126(2):265-8.@@Hanover JA, Cheng S, Willingham MC, Pastan IH: alpha 2-Macroglobulin binding to cultured fibroblasts. Solubilization and partial purification of binding sites. J Biol Chem. 1983 Jan 10;258(1):370-7.@@Gliemann J, Larsen TR, Sottrup-Jensen L: Cell association and degradation of alpha 2-macroglobulin-trypsin complexes in hepatocytes and adipocytes. Biochim Biophys Acta. 1983 Mar 31;756(2):230-7.
GroupsApproved; Vet_approved
Direct ClassificationPolypeptides
SMILESCC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC
Pathways
PharmGKBPA448531
ChEMBLCHEMBL1200558